Executive Chairman of Genomic Health Inc. (GHDX, Financial) Randal W Scott sells 20,000 shares of GHDX on 10/12/2010 at an average price of $13.95 a share.
Genomic Health Inc. has a market cap of $400.6 million; its shares were traded at around $13.9 with and P/S ratio of 2.7.
GHDX is in the portfolios of Chuck Royce of Royce& Associates, Jim Simons of Renaissance Technologies LLC.
Genomic Health Inc. has a market cap of $400.6 million; its shares were traded at around $13.9 with and P/S ratio of 2.7.
GHDX is in the portfolios of Chuck Royce of Royce& Associates, Jim Simons of Renaissance Technologies LLC.
CEO Recent Trades:
- Sell: President and CEO Kimberly J Popovits sold 7,734 shares of GHDX stock on 09/15/2010 at the average price of 15.1. Kimberly J Popovits owns at least 310,624 shares after this. The price of the stock has decreased by 7.95% since.
- Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 08/17/2010 at the average price of 15.07. Kimberly J Popovits owns at least 288,116 shares after this. The price of the stock has decreased by 7.76% since.
- Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 05/17/2010 at the average price of 15.78. Kimberly J Popovits owns at least 310,624 shares after this. The price of the stock has decreased by 11.91% since.
CFO Recent Trades:
- Sell: COO & CFO G Bradley Cole sold 2,500 shares of GHDX stock on 09/13/2010 at the average price of 15.01. G Bradley Cole owns at least 1,000 shares after this. The price of the stock has decreased by 7.4% since.
- Sell: COO & CFO G Bradley Cole sold 2,500 shares of GHDX stock on 08/12/2010 at the average price of 15. G Bradley Cole owns at least 1,000 shares after this. The price of the stock has decreased by 7.33% since.
- Sell: COO & CFO G Bradley Cole sold 2,500 shares of GHDX stock on 05/12/2010 at the average price of 15.87. G Bradley Cole owns at least 1,000 shares after this. The price of the stock has decreased by 12.41% since.
Directors and Officers Recent Trades:
- Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 5,261 shares of GHDX stock on 09/09/2010 at the average price of 14.81. Brothers Life Sciences C Baker owns at least 4,934,990 shares after this. The price of the stock has decreased by 6.14% since.
- Buy: Director, 10% Owner Capital (gp), Llc 14159 bought 145 shares of GHDX stock on 09/09/2010 at the average price of 14.81. Capital (gp), Llc 14159 owns at least 134,196 shares after this. The price of the stock has decreased by 6.14% since.
- Buy: Director, 10% Owner Capital (gp), Llc 14159 bought 1,807 shares of GHDX stock on 09/02/2010 at the average price of 14.46. Capital (gp), Llc 14159 owns at least 134,051 shares after this. The price of the stock has decreased by 3.87% since.
- Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 65,466 shares of GHDX stock on 09/02/2010 at the average price of 14.46. Brothers Life Sciences C Baker owns at least 4,929,729 shares after this. The price of the stock has decreased by 3.87% since.
- Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 123,711 shares of GHDX stock on 08/30/2010 at the average price of 14.37. Brothers Life Sciences C Baker owns at least 4,864,263 shares after this. The price of the stock has decreased by 3.27% since.
